Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body. For more information, please visit the company’s website at www.nkartatx.com.
Company Details
- Employees
- 147
- Founded
- -
- Address
- 1150 Veterans Blvd., South San Francisco,california 94080,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.nkartatx.com
- HQ
- South San Francisco, California
Nkarta, Inc. Questions
Nkarta, Inc.'s website is http://www.nkartatx.com
Nkarta, Inc.'s LinkedIn profile is https://www.linkedin.com/company/nkarta-inc
Nkarta, Inc. has
147 employees.
View email and phone details for 147
employees at Nkarta, Inc..
Nkarta, Inc.'s industry is
Biotechnology Research
Nkarta, Inc.'s top competitors are
Sana Biotechnology, Inc.,
Denali Therapeutics,
Genefab,
Cargo Therapeutics,
Sutro Biopharma, Inc.,
Arsenal Biosciences, Inc.,
Senti Biosciences,
Kyverna Therapeutics,
Allogene Therapeutics,
Caribou Biosciences.
Nkarta, Inc.'s categories are Biotechnology Research
Nkarta, Inc.'s founding year is 2015
